SILO PHARMA, INC. Financing Cash Flow
SILO PHARMA, INC. (SILO) reported Financing Cash Flow of -$27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- SILO PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.13M.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $634.92K, a 63.54% decline year-over-year.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $0.00.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $1.74M.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$471.12K, a 109.54% decline from fiscal 2022.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $4.94M, a 30.23% increase from fiscal 2021.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2021 was $3.79M, a 77.74% increase from fiscal 2020.
- SILO PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2020 was $2.13M, a 457.85% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 15 month | Net Cash Provided by (Used in) Financing Activities 18 month | Net Cash Provided by (Used in) Financing Activities 21 month | Net Cash Provided by (Used in) Financing Activities 24 month | Net Cash Provided by (Used in) Financing Activities 27 month | Net Cash Provided by (Used in) Financing Activities 30 month | Net Cash Provided by (Used in) Financing Activities 33 month | Net Cash Provided by (Used in) Financing Activities 36 month | Net Cash Provided by (Used in) Financing Activities 39 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$27.00K 10-Q · filed 2026-08-13 | ||||||||||||
| 2025-12-31 | $2.13M derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $2.77M derived: sum of 2 quarters · filed 2026-04-14 | $4.86M POS AM · filed 2026-04-14 | ||||||||||
| 2025-09-30 | $634.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.73M 10-Q · filed 2025-11-13 | |||||||||||
| 2025-06-30 | $2.09M 10-Q · filed 2026-08-13 | ||||||||||||
| 2024-12-31 | $0.00 derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $1.74M derived: sum of 2 quarters · filed 2026-04-14 | $3.36M derived: sum of 3 quarters · filed 2026-04-14 | $3.24M POS AM · filed 2026-04-14 | |||||||||
| 2024-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.36M derived: sum of 2 quarters · filed 2025-11-13 | $3.24M 10-Q · filed 2025-11-13 | $3.05M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||
| 2024-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.50M 10-Q · filed 2025-08-13 | $1.31M derived: sum of 3 quarters · filed 2025-08-13 | $1.16M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||
| 2024-03-31 | -$115.45K 10-Q · filed 2025-05-09 | -$309.88K derived: sum of 2 quarters · filed 2025-05-09 | -$455.61K derived: sum of 3 quarters · filed 2025-05-09 | ||||||||||
| 2023-12-31 | -$194.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$340.16K derived: sum of 2 quarters · filed 2025-03-28 | -$471.12K 10-K · filed 2025-03-28 | ||||||||||
| 2023-09-30 | -$145.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$276.70K 10-Q · filed 2024-11-12 | |||||||||||
| 2023-06-30 | -$130.96K 10-Q · filed 2024-08-13 | ||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $4.94M 10-K · filed 2024-03-25 | |||||||||||
| 2022-09-30 | $4.94M 10-Q · filed 2023-11-13 | ||||||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | -$2.37K derived: sum of 3 quarters · filed 2023-03-24 | $3.79M 10-K · filed 2023-03-24 | |||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.37K derived: sum of 2 quarters · filed 2022-11-10 | $3.79M 10-Q · filed 2022-11-10 | $3.79M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||
| 2021-06-30 | -$2.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $3.79M 10-Q · filed 2022-08-01 | $3.79M derived: sum of 3 quarters · filed 2022-08-01 | $3.80M derived: sum of 4 quarters · filed 2022-08-01 | |||||||||
| 2021-03-31 | $3.80M 10-Q · filed 2022-05-13 | $3.80M derived: sum of 2 quarters · filed 2022-05-13 | $3.80M derived: sum of 3 quarters · filed 2022-05-13 | $5.92M derived: sum of 4 quarters · filed 2022-05-13 | |||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.00K derived: sum of 2 quarters · filed 2022-03-28 | $2.12M derived: sum of 3 quarters · filed 2022-03-28 | $2.13M 10-K · filed 2022-03-28 | |||||||||
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.12M derived: sum of 2 quarters · filed 2021-11-10 | $2.13M 10-Q · filed 2021-11-10 | $2.51M derived: sum of 4 quarters · filed 2021-11-10 | |||||||||
| 2020-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.13M 10-Q · filed 2021-08-13 | $2.51M derived: sum of 3 quarters · filed 2021-08-13 | $2.53M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-17 | $395.00K derived: sum of 2 quarters · filed 2021-05-17 | $414.92K derived: sum of 3 quarters · filed 2021-05-17 | $407.46K derived: sum of 4 quarters · filed 2021-05-17 | |||||||||
| 2019-12-31 | $380.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $399.92K derived: sum of 2 quarters · filed 2021-05-17 | $392.46K derived: sum of 3 quarters · filed 2021-05-17 | $382.66K 10-K/A · filed 2021-05-17 | |||||||||
| 2019-09-30 | $19.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $12.46K derived: sum of 2 quarters · filed 2020-11-05 | $2.66K 10-Q · filed 2020-11-05 | ||||||||||
| 2019-06-30 | -$7.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$17.27K 10-Q · filed 2020-08-14 | |||||||||||
| 2019-03-31 | -$9.81K 10-Q · filed 2020-05-12 | ||||||||||||
| 2018-12-31 | $19.45K 10-K · filed 2020-03-20 | ||||||||||||
| 2013-12-31 | $872.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.77M derived: sum of 2 quarters · filed 2014-03-31 | $2.17M derived: sum of 3 quarters · filed 2014-03-31 | $2.19M 10-K · filed 2014-03-31 | |||||||||
| 2013-09-30 | $899.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.30M derived: sum of 2 quarters · filed 2013-11-14 | $1.32M 10-Q · filed 2013-11-14 | $1.32M derived: sum of 4 quarters · filed 2014-03-31 | $1.39M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $420.00K 10-Q · filed 2013-08-08 | $425.00K derived: sum of 3 quarters · filed 2014-03-31 | $425.00K derived: sum of 4 quarters · filed 2014-03-31 | $491.56K 10-Q · filed 2013-08-08 | ||||||||
| 2013-03-31 | $20.00K 10-Q · filed 2013-05-15 | $25.00K derived: sum of 2 quarters · filed 2014-03-31 | $25.00K derived: sum of 3 quarters · filed 2014-03-31 | $25.00K derived: sum of 4 quarters · filed 2014-03-31 | $91.56K 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.00K derived: sum of 2 quarters · filed 2014-03-31 | $5.00K derived: sum of 3 quarters · filed 2014-03-31 | $20.00K 10-K · filed 2014-03-31 | $71.56K 10-K · filed 2013-03-05 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $15.00K 10-Q · filed 2013-11-14 | $15.00K derived: sum of 4 quarters · filed 2014-03-31 | $66.56K 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $15.00K 10-Q · filed 2013-08-08 | $15.00K derived: sum of 3 quarters · filed 2014-03-31 | $15.00K derived: sum of 4 quarters · filed 2014-03-31 | $66.56K 10-Q · filed 2012-08-01 | ||||||||
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-15 | $15.00K derived: sum of 2 quarters · filed 2014-03-31 | $15.00K derived: sum of 3 quarters · filed 2014-03-31 | $15.00K derived: sum of 4 quarters · filed 2014-03-31 | $66.56K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $575.00 10-K · filed 2014-03-31 | $51.56K 10-K · filed 2012-01-26 | ||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $575.00 10-Q · filed 2012-11-13 | $51.56K 10-Q · filed 2011-11-10 | |||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $575.00 10-Q · filed 2012-08-01 | $51.56K 10-Q · filed 2011-08-15 | ||||||||||
| 2011-03-31 | $575.00 10-Q · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $50.98K 10-K · filed 2012-01-26 | ||||||||||||
| 2010-09-30 | $8.50K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |